Your browser doesn't support javascript.
loading
Differential and limited expression of mutant alleles in multiple myeloma.
Rashid, Naim U; Sperling, Adam S; Bolli, Niccolo; Wedge, David C; Van Loo, Peter; Tai, Yu-Tzu; Shammas, Masood A; Fulciniti, Mariateresa; Samur, Mehmet K; Richardson, Paul G; Magrangeas, Florence; Minvielle, Stephane; Futreal, P Andrew; Anderson, Kenneth C; Avet-Loiseau, Herve; Campbell, Peter J; Parmigiani, Giovanni; Munshi, Nikhil C.
Afiliación
  • Rashid NU; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Biostatistics, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA;
  • Sperling AS; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Bolli N; Department of Cancer Genetics and Genomics, Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom; Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom;
  • Wedge DC; Department of Cancer Genetics and Genomics, Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom;
  • Van Loo P; Department of Cancer Genetics and Genomics, Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom; Department of Human Genetics, Vlaams Instituut voor Biotechnologie and University of Leuven, Leuven, Belgium;
  • Tai YT; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Shammas MA; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Hematology/Oncology, Boston Veterans Administration Healthcare System, West Roxbury, MA;
  • Fulciniti M; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Samur MK; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Biostatistics, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA;
  • Richardson PG; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Magrangeas F; Hematology Department, Centre de Recherche en Cancérologie Nantes-Angers Unité Mixte de Recherche INSERM 892-Centre National de la Recherche Scientifique 6299 and Institut de Recherche Thérapeutique de l'Université de Nantes, Nantes, France;
  • Minvielle S; Hematology Department, Centre de Recherche en Cancérologie Nantes-Angers Unité Mixte de Recherche INSERM 892-Centre National de la Recherche Scientifique 6299 and Institut de Recherche Thérapeutique de l'Université de Nantes, Nantes, France;
  • Futreal PA; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX;
  • Anderson KC; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Avet-Loiseau H; Unité de Génomique du Myélome, Centre Hospitalier Universitaire Rangueil, Toulouse, France; and Centre de Recherche en Cancérologie de Toulouse, INSERM U1037, Toulouse, France.
  • Campbell PJ; Department of Cancer Genetics and Genomics, Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom; Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom;
  • Parmigiani G; Department of Biostatistics, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA;
  • Munshi NC; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Hematology/Oncology, Boston Veterans Administration Healthcare System, West Roxbury, MA;
Blood ; 124(20): 3110-7, 2014 Nov 13.
Article en En | MEDLINE | ID: mdl-25237203
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Mieloma Múltiple / Mutación Límite: Humans Idioma: En Revista: Blood Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Mieloma Múltiple / Mutación Límite: Humans Idioma: En Revista: Blood Año: 2014 Tipo del documento: Article